Search for a funded project
Explorez notre base de projets financés
NSP3 polyprotein of SARS-CoV2: structural studies and its exploration in drug screening campaign – COVNSP3
alarming emerging infectious disease caused by coronavirus (CoV). The current COVID-19 pandemic, which [...] Wuhan region of China, is caused by a novel coronavirus, SARS-CoV2 which is more infectious than the
Interventions for Covid-19 infection: a living mapping of research and a series of living network meta-analyses – living-NMA-covid
Context: In December 2019, a novel coronavirus outbreak was documented in Wuhan, Hubei Province, China [...] first 6 weeks of the new decade, this novel coronavirus, known as SARS-CoV-2, has spread from China to
REpresentations, PErceptions and Attitudes to the COVID-19 virus – REPEAT
variety of countries differently exposed to the coronavirus. Contrary to conventional research projects,
Natural History of SARS-CoV2 : Emergence and Reservoir – DisCoVer
December 2019, a new disease named COVID-19 (COronaVirus Infectious Disease 2019), due to a new Betac
Regulating Wetmarkets in Central China : Ethnographic Study of the Perception of Zoonotic Risks after the Covid-19 Crisis – RegWet
which was the epicenter of emergence of this new coronavirus transmitted from bats to animals sold for human
The role of the Army in the "war" against the coronavirus and its perception by the population – ARMY
on of the military in the fight against the coronavirus, designated as an "invisible enemy". The objective
Systemic and mucosal immune response variation during SARS-CoV-2 infection and recovery – CoVarImm
Coronavirus disease (COVID-19) is an infectious disease that primarily targets the human respiratory [...] virus denoted ‘Severe Acute Respiratory Syndrome coronavirus 2’ (SARS-CoV-2). The immune response to SARS-CoV-2 [...] Nevertheless, immune responsiveness to this novel coronavirus appears quite variable in humans as indicated
A TARGETED METABOMOLIC APPROACH TO DESIGN A PREDICTIVE MODEL FROM THE MONITORING OF THE INFLAMMATORY MEDIATORS KINETICS IN PATIENTS ADMITTED TO INTENSIVE CARE UNIT WITH COVID-19 PNEUMONIA. – COVID-METAFLAM
Beginning in December 2019, a novel coronavirus, designated SARS-CoV-2, has caused an international outbreak
COVID 19 Rapid diagnosis test (development and clinical validation in 7 weeks) – CORaDiag
an acute respiratory disease caused by novel coronavirus SARS-CoV-2 also known as 2019-nCoV. On March
Role of SARS-CoV-2-infected pulmonary cells and antibody response in COVID-19 outcomes: From pathophysiology to testing candidate drugs in mucosal cell models – MUCOLUNG
Syndrome)-CoV (Corona virus)-2 is a novel airborne coronavirus threatening public health that is currently spreading